When: Third test with confirmed close below on volume ≥50M

Then: Validate further trimming to 25% range

When: MACD histogram contracting for two sessions

Then: Technical repair trigger pausing all further trims

BUY (trim 30-50% of position in phased manner, preserve remaining long exposure to 18-36 month catalysts)

• Tesla has $43.5B cash and short-term investments, 18 basis point debt-to-equity ratio, no goodwill, no preferred stock, and $3.94B quarterly operating cash flow—fundamentally incomparable to Lehman's 2007 solvency crisis
• At 144x forward earnings with 1.4% operating margin and 420 basis points of gross margin compression in one quarter, the aggressive analyst correctly identifies unsustainable multiples but overshoots with full exit recommendation
• The stock is already down 26% in July, traded to $298 on July 29th, and RSI printed 25.42—extreme oversold territory historically marking capitulation zones with asymmetric reversion risk to upside
• A full exit surrenders Terafab/Optimus call option value, creates execution risk given 1.83 beta and ~$15 ATR, and bets against reversion at deeply oversold levels
• SpaceX Megapack purchases were $295M in Q2 and $329M in H1—real revenue confirming Terafab is not vaporware
• HOLD is the most dangerous position because it absorbs full drawdown risk (~15% to lower Bollinger band at ~$270) while the same optionality is preserved with a 30-50% trim
• Gross margin compression is structural not transient, capex is at company record highs, and competitive pressure intensifying with Ford Fathom at $28,350 and BYD gaining global share
• Sentiment score is 4.8/10 with low confidence and StockTwits unavailable—no retail conviction data means contrarian short squeeze risk is elevated on positive headlines
• Stop-loss at $347 above $319 entry implies naked short exposure, which is inappropriate given RSI 25.42, binary FSD EU and Terafab catalysts, and elevated squeeze risk—defined-risk options structures like collars are preferable for hedging
• Trim should be phased across multiple sessions given $15 ATR and high slippage risk; re-entry framework should be defined before execution with specific technical triggers

→ vs aggressive: Full exit recommendation ignores $43.5B cash position, 18bp debt-to-equity, and $3.94B quarterly operating cash flow that make Lehman comparison intellectually dishonest; also surrenders call option value on 18-36 month Terafab/Optimus catalysts and creates execution risk in a 1.83-beta name with ~$15 ATR

→ vs neutral: HOLD position is institutional paralysis dressed as patience—accepting ~15% additional drawdown risk to $270 lower Bollinger when gross margin compression is structural not transient, capex is at company record, and Ford Fathom ($28,350) and BYD intensify competition; the same Terafab optionality is preserved with a 30-50% trim, making full HOLD exposure an unnecessary risk

TRIM (30-50% reduction, phased over 3-5 sessions)

• 30-50% trim is correct based on fundamental deterioration, not technicals
• Gross margin compressed 420bps in single quarter; operating margin at 1.4%; FCF turned negative; capex running more than double historical rate
• Trim should be phased over 3-5 sessions to reduce execution slippage in volatile name (ATR ~$15)
• Stop loss at 347 should be replaced with put spread or collar - current structure either doesn't work or carries unacknowledged risks
• Re-entry triggers: add back half position above 50 SMA at 383 on closing basis with above-average volume; full re-add on confirmed break above 200 SMA at 409 with sustained volume
• Portfolio repositioning: if TSLA is 15% of portfolio, trim brings it to 7.5-10.5% for better risk profile
• Macro environment (no Fed cuts, no recession) supports multiple compression thesis but not capitulation - trim size reflects this not recession risk
• Aggressive analyst's historical analogies (Lehman) are rhetorical rather than analytical; data does not support existential thesis

→ vs aggressive: Lehman Brothers comparison activates fear response rather than making analytical point; Tesla holds $43.5B liquidity, $4.7B operating cash flow, zero goodwill - not structurally broken

→ vs conservative: Assuming 'worst is priced in' means assuming we know where the bottom is; we don't; negative news flow (FSD Netherlands, Ford Fathom, Unitree IPO) represents structural competitive shifts, not transient noise

→ vs aggressive: Short from 319 with stop at 347 carries unbounded risk in 1.83 beta name with $15 ATR and binary catalysts (FSD EU approval, Terafab milestones); one good headline squeezes the position

→ vs conservative: HOLD was never viable once Q2 fundamentals hit; underselling how much multiple compression can still occur from these levels